Abstract

Sepsis survivors suffer from increased vulnerability to infections, and lymphopenia presumably contributes to this problem. The mechanisms of the recovery of memory CD4+ T cells after sepsis remain elusive. We used the cecal ligation and puncture mouse model of sepsis to study the restoration of the memory CD4+ T cells during recovery from sepsis. Then, adoptive transfer of antigen-specific naive CD4+ T cells followed by immunization and BrdU labeling were performed to trace the proliferation and migration of memory CD4+ T cells. We revealed that the bone marrow (BM) is the primary site of CD4+ memory T cell homing and proliferation after sepsis-induced lymphopenia. Of interest, BM CD4+ T cells had a higher basal proliferation rate in comparison with splenic T cells. These cells also show features of resident memory T cells yet have the capacity to migrate outside the BM niche and engraft secondary lymphoid organs. The BM niche also sustains viability and functionality of CD4+ T cells. We also identified IL-7 as the major inducer of proliferation of the BM memory CD4+ T cells and showed that recombinant IL-7 improves the recovery of these cells. Taken together, we provide data on the mechanism and location of memory CD4+ T cell proliferation during recovery from septic lymphopenia, which are of relevance in studying immunostimulatory therapies in sepsis.

Highlights

  • Because of a high prevalence and unacceptably high mortality, sepsis has been called a global health priority in a World Health Organization resolution [1]

  • By the means of adoptive transfer of OVA-specific CD4+ T cells with subsequent immunization and cecal ligation and puncture (CLP), we showed that bona fide memory helper T cells proliferate and expand in the bone marrow (BM) during the recovery phase of sepsis in an IL-7–dependent mechanism, and a fraction of these cells migrates to the periphery

  • Because we found that the recovery of BM CD4+ T cells depends on the local IL-7 availability, we tested whether this process can be enhanced by treatment with exogenous IL-7 (Figure 7A)

Read more

Summary

Introduction

Because of a high prevalence and unacceptably high mortality, sepsis has been called a global health priority in a World Health Organization resolution [1]. Despite several reports showing trends of decreasing sepsis-associated mortality over recent years [3], other analyses reach less optimistic conclusions [4]. Surviving sepsis negatively affects the long-term health of the patient and increases the risk of later death [5]. Among many other negative outcomes, sepsis impairs the immune system, leading to both short- and long-term infectious complications [6]. A better understanding of the pathogenesis of sepsis and its impact on the patient’s immune competence are urgently needed

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call